Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

First Line Treatment of Elderly Patients With Advanced or Metastatic NSCLC With Docetaxel and Bevacizumab

Authors not listed

Hellenic Oncology Research Group · 2010

Abstract

The investigators propose to study the efficacy and safety of the combination of Docetaxel plus Bevacizumab in a Phase II trial of elderly subjects with non-small cell lung cancer

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Anonymous. (2010). First Line Treatment of Elderly Patients With Advanced or Metastatic NSCLC With Docetaxel and Bevacizumab. <em>Hellenic Oncology Research Group</em>. https://clinicaltrials.gov/study/NCT02179567
Vancouver
Anonymous. First Line Treatment of Elderly Patients With Advanced or Metastatic NSCLC With Docetaxel and Bevacizumab. Hellenic Oncology Research Group. 2010.
BibTeX
@misc{anon2010FirstL, title = {First Line Treatment of Elderly Patients With Advanced or Metastatic NSCLC With Docetaxel and Bevacizumab}, author = {Anonymous}, journal = {Hellenic Oncology Research Group}, year = {2010}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings